4.3 Review

GPIHBP1 and lipolysis: an update

Journal

CURRENT OPINION IN LIPIDOLOGY
Volume 20, Issue 3, Pages 211-216

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MOL.0b013e32832ac026

Keywords

chylomicrons; endothelial; lipoprotein lipase; PPAR gamma

Funding

  1. National Heart, Lung, and Blood Institute [5P01 HL090553-02, 5R01 HL087228-02]
  2. American Heart Association Scientist Development Award
  3. Ruth L. Kirschstein NRSA [T32HL69766]

Ask authors/readers for more resources

Purpose of review This review will provide an update on the structure of GPIHBP1, a 28-kDa glycosylphosphatidylinositol-anchored glycoprotein, and its role in the lipolytic processing of triglyceride-rich lipoproteins. Recent findings Gpihbp1 knockout mice on a chow diet have milky plasma and plasma triglyceride levels of more than 3000 mg/dl. GPIHBP1 is located on the luminal surface of endothelial cells in tissues where lipolysis occurs: heart, skeletal muscle, and adipose tissue. The pattern of lipoprotein lipase (LPL) release into the plasma after an intravenous injection of heparin is abnormal in Gpihbp1-deficient mice, suggesting that GPIHBP1 plays a direct role in binding LPL within the tissues of mice. Transfection of CHO cells with a GPIHBP1 expression vector confers on cells the ability to bind both LPL and chylomicrons. Two regions of GPIHBP1 are required for the binding of LPL - an amino-terminal acidic domain and the cysteine-rich Ly6 domain. GPIHBP1 expression in mice changes with fasting and refeeding and is regulated in part by peroxisome proliferator-activated receptor-gamma. Summary GPIHBP1, an endothelial cell-surface glycoprotein, binds LPL and is required for the lipolytic processing of triglyceride-rich lipoproteins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available